Assessment of Antibiotic Resistance Pattern of Bacteria Prevalent during COVID-19 Pandemic

Abdulrahman Hadi Almutiri,Khaled Abdulrahman Aldhwaihi,Saad Aldoihi,Saud M Alsanad

doi:10.9734/jpri/2021/v33i57a33975

Abdulrahman Hadi Almutiri, Khaled Abdulrahman Aldhwaihi + Show 2 more

Open Access

PDF Available

https://doi.org/10.9734/jpri/2021/v33i57a33975

Copy DOI

Export

Save

Cite

Abstract
Highlights/Summary
Full-Text PDF
Similar Papers

Abstract

Listen

Owing to disparities in the intensity of the breakouts, state and federal regulations, accessible means, cultural elements, and social consciousness, the global reaction to the COVID-19 pandemic has been varied. The COVID-19 pandemic, on the other hand, has had an impact on all parts of society, notably efforts to combat antimicrobial resistance (AMR). The pandemic has highlighted that a greater burden on medical infrastructure can contribute to higher, often unnecessary antibiotic usage and a de-prioritization of antimicrobial stewardship and surveillance (AMS). The focus of this research is to see if there is a growth in antibiotic resistance during the covid-19 pandemic in the King Salman Hospital in Riyadh, Saudi Arabia, and to investigate the subcomponent that leads to antibiotic resistance. This is a comprehensive review of patients hospitalized at the King Salman Hospital in Riyadh, Saudi Arabia, who were admitted to the Intensive Care Unit (ICU) during the first wave of the covid-19 pandemic, which occurred between March and August 2020. An analysis of the case dataset was performed to determine the rise in antibiotic resistance and relate it to resistant cases before the pandemic (September 2019 to February 2020). Before and throughout the pandemic, fifteen kinds of bacteria were found, with K. pneumonia being the most prevalent bacteria (49; 30.6%), and Ac. Baum/haem being the most removable bacteria during the pandemic (74; 37.3%). Cephalosporin antibiotics, in notably cefotaxime and ceftazidime (100%), cefazolin (96.3%), ceftriaxone (96%), cefuroxime and ceftazidime (95%), cefotaxime ((94.7%). These antibiotics also had the same amount of resistance during the pandemic. In pre-covid-19 and during covid-19, these findings were congruent with the penicillin antibiotics class, ampicillin, and piperacillin (96.3% and 92.1%), accordingly. It is presently uncertain if COVID-19 patients would develop new or growing antibiotic resistance in locations with low historical prevalence, but this should be investigated in retrospective and future clinical and microbiology research.

Highlights

Given the disparity in the intensity of the breakouts, state and federal regulations, accessible means, cultural elements, and social consciousness, the global reaction to the COVID19 pandemic has been varied
The focus of this research is to see if there is a growth in antibiotic resistance throughout the covid-19 pandemic in the King Salman Hospital in Riyadh, Saudi Arabia, and to investigate the contributing elements that lead to antibiotic resistance. This is a retrospective analysis of patients hospitalized at the King Salman Hospital in Riyadh, Saudi Arabia, who were hospitalized to the Intensive Care Unit (ICU) during the first wave of the covid-19 pandemic, which occurred between March and August 2020
Roughly 160 microbiological sensitivity tests were requested from 13 wards in the hospital before the pandemic, with the most coming from the ICU (58 requests)

Summary

Introduction

Given the disparity in the intensity of the breakouts, state and federal regulations, accessible means, cultural elements, and social consciousness, the global reaction to the COVID19 pandemic has been varied. On the other hand, attempted to guarantee that their health-care systems could deal with a highpredicted percentage of acute cases, but a variety of strategies were used, spanning from rigorous, mandated lockdowns to ambiguous and encouraging physical distancing advice [1,2]. More information is needed, early information (discussed below) suggests that outpatient antibiotic usage has been reduced in several contexts. This could be owing to an absence of availability to healthcare because of lockdowns and physical distancing, or it could be owing to a reduction in the transmission of other pathogens in specific circumstances or a mix of the two. Initially in the COVID-19 pandemic, treating the large percentage of hospitalized COVID-19 patients with antibiotics, boosted antibiotic consumption relative to the prepandemic timeframe [7,8,9]

Methods

Results

Conclusion